Clinigen Group plc, the global pharmaceutical and services company, and CHEPLAPHARM Arzneimittel GmbH (‘CHEPLAPHAR...
THC Global Group Limited (THC Global or the Company) has announced that its Southport Facility was opened by the Federal...
Nano-sensors on the tip of the diagnostic stick measure heart disease biomarkers to accurately predict the risk of heart...
Australia’s leading gut microbiome testing specialists Microba have partnered with the Microbiome Research Centre ...
Australian medical researchers from the Centenary Institute and the University of Sydney have successfully developed and...
eConsent App The Evado eConsent App is targeted at any health related organisation that needs to record patient c...
Melbourne based Propanc Biopharma Inc., a biopharmaceutical company developing new cancer treatments for patients suffer...
Australia based Medical device company Q-Sera Pty Ltd has announced that it has received a Notice of Allowance from the ...
GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging has announced a new research collab...
The iQ Group Global is honoured to be recognised as one of Australia and New Zealand's Top...
Leading medical research institutes and universities in Western Australia have announced a new partnership with ANDHealt...
Global Diagnostics Australia (GDA), a subsidiary of the Integral Diagnostics Group (IDX), has announced that it has adop...
SpeeDx Pty. Ltd., an Australia based developer of disruptive new molecular diagnostic solutions has announced that it ha...
Australian patients with diabetes-induced eye disease can now access a new treatment option that provides consistent and...
Chemist Warehouse, on 5 August 2019, announced its partnership with SmileDirectClub, the US-based&nb...
Australia headquartered Clinical stage cannabinoid company Botanix Pharmaceuticals has announced the receipt of firm com...
Biocon Ltd. and Mylan N.V. have announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar...
Alterity Therapeutics Limited has announced that it has successfully completed its Phase 1 study of PBT434, a novel, ora...
